Acidi Grassi e Derivati Lipidici

<p>Stability Light Sensitive<br>Applications γ-Linolenic Acid is a fatty acid found mainly in vegetable oil. Studies suggest that γ-Linolenic Acid may have immune regulating and anti-inflammatory effects. γ-Linolenic Acid has also been used in the treatment of atopic eczeme although its efficacy is disputed.<br>References Ziboh, V. et al.: Fatty Acids Food Health Implic., 791 (2008); Kapoor, R. et al.: Curr. Phar, Biotechnol., 7, 531 (2006); Horrobin, D. et al.: Am. J. Nutrit., 71, 367S (2000);<br></p>

<p>Applications Glycine conjugated Hyodeoxycholate, facilitates the biological transport of Hyodeoxycholate within the intestine<br>References Yang, L., et al.: Chem. Res. Toxicol. 21, 2280 (2008), Sato, H., et al.: J. Med. Chem., 51, 4849 (2008), Gnewuch, C., et al.: World J. Gastroenterol., 15, 3134 (2009),<br></p>

<p>Applications Bempedoic Acid is used for the treatment of dyslipidemia and other cardio-metabolic risk factors (1). It inhibits ATP citrate lyase (ACL), which an enzyme involved in fatty acid and cholesterol synthesis (2).<br>References (1) Pinksoskyl, S. L., et al.: J Lipid Res. 54, 134 (2013) (2) Pinksoskyl, S. L., et al.: Nat Commun. 7, 13457 (2016)<br></p>

<p>Stability Hygroscopic<br>Applications Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from their use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic.<br>References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),<br></p>

<p>Impurity Probucol USP Related Compound A<br>Applications Tetra-tert-butyldiphenoquinone is an antioxident used in the prevention of aging/rusting in dyes, rubber and textiles. Metabolite of Probucol (P755100) an antilipemic. Probucol USP Related Compound A.<br>References Bukharov, S.et al.: Russ J. Green Chem., 72, 1805 (2002); Shanina, E. et al.: Aging Polym. Polym. Blends Polym. Compos., 2, 189 (2002); Shakir, D., et al.: J. Clin. Med. Res., 1, 8 (2009), Kubo, Y., et al.: Biol. Pharm. Bull., 32, 1880 (2009), Gohil, V., et al.: Nat. Biotechnol., 28, 249 (2010),<br></p>

<p>Stability Light and Temperature Sensitive<br>Applications A synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and ischemia. It acts through elevation of cAMP by binding to the prostacyclin receptor (IP receptor). Iloprost inhibits the ADP, thrombin, and collagen-induced aggregation of human platelets with an ED50 of about 13 nM. In whole animals, iloprost acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time.<br>References Zamudio, T.P.: Arch. Cardiol. Mex., 77, 198 (2007); Lai, Y. et al.: Am. J. Resp. Crit. Care Med., 178, 188 (2008); Scorza, R. et al.: J. Rheutamol., 24, 1944 (1997); Melillo, E. et al.: Int. J. Microcircul. Clin. Exp., 15, 60 (1995);<br></p>

<p>Applications Antilipemic. It is a lipid regulating drug. Increases high density lipoprotein levels by reducing cholesteryl ester transfer protein expresion.<br>References Sornay, R., et al.: Arzneim.-Forsch., 26, 885 (1976), Wulfert, W., et al.: Artery, 9, 120 (1981), Chaput, et al.: Lipids, 34, 497 (1999),<br></p>